Ghent University Academic Bibliography

Advanced

Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years

Van Den Bosch, Filip, DEVINCK, MIEKE, Kruithof, Elli, Hoffman, Ilse, VERBRUGGEN, G, De Keyser, Filip UGent, Mielants, Herman and Veys, Eric (2005) ARTHRITIS AND RHEUMATISM. 52(9).
Please use this url to cite or link to this publication:
author
organization
year
type
conference
publication status
published
subject
in
ARTHRITIS AND RHEUMATISM
Arthritis Rheum.
volume
52
issue
9
pages
S635-S635 pages
publisher
WILEY-LISS
Web of Science type
Meeting Abstract
Web of Science id
000232207803256
JCR category
RHEUMATOLOGY
JCR impact factor
7.421 (2005)
JCR rank
1/22 (2005)
JCR quartile
1 (2005)
ISSN
0004-3591
language
English
UGent publication?
yes
classification
C3
id
350573
handle
http://hdl.handle.net/1854/LU-350573
date created
2006-04-07 15:55:00
date last changed
2016-12-19 15:36:20
@inproceedings{350573,
  author       = {Van Den Bosch, Filip and DEVINCK, MIEKE and Kruithof, Elli and Hoffman, Ilse and VERBRUGGEN, G and De Keyser, Filip and Mielants, Herman and Veys, Eric},
  booktitle    = {ARTHRITIS AND RHEUMATISM},
  issn         = {0004-3591},
  language     = {eng},
  number       = {9},
  pages        = {S635-S635},
  publisher    = {WILEY-LISS},
  title        = {Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years},
  volume       = {52},
  year         = {2005},
}

Chicago
Van Den Bosch, Filip, MIEKE DEVINCK, Elli Kruithof, Ilse Hoffman, G VERBRUGGEN, Filip De Keyser, Herman Mielants, and Eric Veys. 2005. “Preliminary Evidence for a Retardation of Structural Damage in Patients with Ankylosing Spondylitis Continuously Treated with Infliximab for 4 Years.” In Arthritis and Rheumatism, 52:635. WILEY-LISS.
APA
Van Den Bosch, F., DEVINCK, M., Kruithof, E., Hoffman, I., VERBRUGGEN, G., De Keyser, F., Mielants, H., et al. (2005). Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years. ARTHRITIS AND RHEUMATISM (Vol. 52, p. 635). WILEY-LISS.
Vancouver
1.
Van Den Bosch F, DEVINCK M, Kruithof E, Hoffman I, VERBRUGGEN G, De Keyser F, et al. Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years. ARTHRITIS AND RHEUMATISM. WILEY-LISS; 2005. p. 635.
MLA
Van Den Bosch, Filip, MIEKE DEVINCK, Elli Kruithof, et al. “Preliminary Evidence for a Retardation of Structural Damage in Patients with Ankylosing Spondylitis Continuously Treated with Infliximab for 4 Years.” Arthritis and Rheumatism. Vol. 52. WILEY-LISS, 2005. 635. Print.